Tetromycin B (CAS 180027-84-3)

Tetromycin B, with the CAS number 180027-84-3, is a naturally occurring antibiotic compound belonging to the tetronate class, similar to its analog Tetromycin A. This compound is produced by certain strains of the bacterium Streptomyces. Structurally, Tetromycin B features a distinctive tetronic acid core linked to a macrocyclic lactone ring, a hallmark of the tetronate antibiotics, which is crucial for its bioactivity. The action mechanism of Tetromycin B involves the inhibition of bacterial type II topoisomerases such as DNA gyrase and topoisomerase IV. These enzymes are essential for controlling the topological states of DNA during various cellular processes such as replication, transcription, and chromosome segregation. Tetromycin B acts by binding to the topoisomerase-DNA complex, stabilizing it and thereby blocking the religation step of the DNA breakage-reunion cycle essential for normal DNA transaction processes. This blockage leads to the accumulation of DNA breaks, disrupting essential cellular processes and ultimately resulting in cell death. In the research domain, Tetromycin B has been extensively used to explore the dynamics of bacterial DNA replication and segregation. It serves as an invaluable probe for understanding the detailed molecular mechanisms by which topoisomerases operate and the potential pathways through which bacteria develop resistance to topoisomerase inhibitors. This research is significant as it aids in the broader understanding of bacterial cell physiology and has implications for the development of new strategies to tackle bacterial growth where resistance to current treatments is prevalent.